| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.816 | 29.100 | 32.167 | 37.889 | 46.698 | 47.465 | 56.453 | 58.109 | 70.231 | 82.751 |
| Total Income - EUR | 28.817 | 29.101 | 32.167 | 37.890 | 46.700 | 49.533 | 56.454 | 58.110 | 70.232 | 82.752 |
| Total Expenses - EUR | 18.340 | 18.449 | 18.004 | 15.003 | 15.882 | 21.148 | 23.616 | 35.408 | 40.817 | 47.111 |
| Gross Profit/Loss - EUR | 10.476 | 10.652 | 14.163 | 22.887 | 30.818 | 28.385 | 32.838 | 22.702 | 29.415 | 35.641 |
| Net Profit/Loss - EUR | 9.612 | 10.420 | 13.842 | 22.508 | 30.351 | 27.924 | 32.274 | 22.121 | 28.713 | 33.158 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medverdi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 41 | 0 | 0 | 326 | 1.360 | 1.746 | 2.701 | 31.366 | 24.332 | 2.529 |
| Current Assets | 19.138 | 27.623 | 14.720 | 22.789 | 29.643 | 59.105 | 60.356 | 47.362 | 73.230 | 97.748 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.178 | 820 | 2.188 | 2.730 | 3.391 | 247 | 585 | 515 | 8.018 | 2.252 |
| Cash | 15.960 | 26.802 | 12.532 | 20.059 | 26.252 | 58.858 | 59.771 | 46.847 | 65.212 | 95.496 |
| Shareholders Funds | 17.766 | 26.669 | 13.894 | 22.560 | 30.160 | 57.512 | 60.209 | 58.179 | 84.065 | 98.661 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.413 | 953 | 826 | 555 | 843 | 3.339 | 2.849 | 20.550 | 13.496 | 1.617 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medverdi Srl